|

12-Day Production of Car-T Cells Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • Medical College of Wisconsin1

Indications

  • Non-Hodgkin Lymphoma (NHL)1
  • Central Nervous System Lymphoma1
  • Mantle Cell Lymphoma (MCL)1
  • Primary Mediastinal Large B-cell Lymphoma (PMBCL)1
  • Chronic Lymphocytic Leukemia (CLL)1

Milwaukee, Wisconsin1 trial

CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies

Medical College of Wisconsin and Froedtert Hospital

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.